213895-35-3

Upstream product

• 153059-35-9 1,2:3,4:5,6-tri-O-isopropylidene-L-mannitol 
• 153059-36-0 3,4-O-isopropylidene-L-mannitol 

Downstream Products

• 213895-40-0 N1,N6-di<(1S)-2-methyl-1-(benzyloxycarbonyl)propyl>-(2R,3R,4R,5R)-2,5-di(benzyloxy)-3,4-dihydroxy-3,4-O-isopropylidenehexanediamide 
• 213895-39-7 N1,N6-di<(1S)-2-phenyl-1-(methoxycarbonyl)ethyl>-(2R,3R,4R,5R)-2,5-di(benzyloxy)-3,4-dihydroxy-3,4-O-isopropylidenehexanediamide 
• 213895-43-3 N1,N6-di<(1S)-3-methyl-1-(methoxycarbonyl)butyl>-(2R,3R,4R,5R)-2,5-di(benzyloxy)-3,4-dihydroxy-3,4-O-isopropylidenehexanediamide 
• 213895-50-2 B268 
• 213895-44-4 N₁,N₆-disuccinimidyl-(2R,3R,4R,5R)-2,5-di(benzyloxy)-3,4-O-isopropylidenehexanediamide 
• 213895-38-6 N1,N6-di<(1S)-2-methyl-1-(methoxycarbonyl)propyl>-(2R,3R,4R,5R)-2,5-di(benzyloxy)-3,4-dihydroxy-3,4-O-isopropylidenehexanediamide 
• 213895-42-2 N1,N6-di<(1S)-2-methyl-1-(hydroxymethyl)propyl>-(2R,3R,4R,5R)-2,5-di(benzyloxy)-3,4-dihydroxy-3,4-O-isopropylidenehexanediamide 

Relevant academic research and scientific papers

Design and synthesis of new potent C2-symmetric HIV-1 protease inhibitors. Use of L-mannaric acid as a peptidomimetic scaffold

A study on the use of derivatized carbohydrates as C2-symmetric HIV-1 protease inhibitors has been undertaken. L-Mannaric acid (6) was bis-O- benzylated at C-2 and C-5 and subsequently coupled with amino acids and amines to give C2-s